Sydney Lupkin

speaker

1,064 appearances 108 recordings 3 series first heard Dec 2024 last heard 4d ago

Sydney Lupkin’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 93 in all, peaking in Jul 2026 with 21.

newest first · ▶ plays the moment

Short Wave · GLP-1 Pills Are On The Way. Here's What To Know · 19 Dec 2025 podcast

Examples include Ozempic, which is kind of the Kleenex of GLP-1 drugs, but is actually officially for type 2 diabetes, and Wegovi.

These are drugs you inject under the skin once a week.

And these injectable drugs have become a valuable tool for millions of people trying to get to a healthier weight.

We're talking people who've never been able to lose weight and keep it off finally finding something that works for them.

For sure.

And, you know, they're not for everyone or for every wallet.

Injectables do have a sticker price of over $1,000 a month.

And insurance coverage has been tricky to navigate for a lot of people.

So there is a lot of excitement around a new pill form of the drug.

We're going to talk about two types of these pills.

The first is a Wagobe pill that's expected to win FDA approval by the end of the year.

And then there's another kind of obesity pill that could be right behind it.

And what FDA approval would mean for affordability and access.

GLP-1s.

So, yeah, I talked about this with Andrea Trena.

Her background is in clinical pharmacy, and now she's an obesity director at Novo Nordisk.

That's the company that makes Ozempic and Wegovy.

And Emily, at my request, she went full frizzle during our interview.

100%.

Here is her primer on GLP-1s.

Showing 661–680 of 1,064 · page 34 of 54